Free Trial

Extend gains, led by the positive risk sentiment

RAND

Rand extend gains, led by the more positive risk sentiment, following overnight news that AstraZeneca have restarted a U.K. Trial.

  • Main support area of interest is still seen further out, at 16.5497, August low and best level since July, USDZAR is now 16.63.
  • Focus this week, will be on Thursday, and the SARB rate decision, when the economists surveys expects a 25bps cut to 3.25%.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.